Smartwatch and glucose monitor team up to motivate cancer survivors
NCT ID NCT05490641
First seen Feb 16, 2026 · Last updated Jun 23, 2026 · Updated 18 times
Summary
This study tested whether showing cancer survivors real-time feedback from a continuous glucose monitor and activity tracker could motivate them to exercise more. Sixty cancer survivors at high risk for type 2 diabetes wore a Fitbit and received personalized text messages for 12 weeks. The goal was to see if this approach was feasible and could increase daily physical activity.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The University of Texas at Arlington
Arlington, Texas, 76010, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Glucose-based biofeedback via continuous glucose monitor and Fitbit activity tracker
What this could lead to
If successful, this approach could help cancer survivors become more active and reduce their risk of type 2 diabetes.
What could go wrong
This is a small, early feasibility study with only 60 participants. It tests whether the method works, not whether it improves health outcomes.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.